• 1
    Akira, S. and Takeda, K., Toll-like receptor signalling. Nat. Rev. Immunol. 2004. 4: 499511.
  • 2
    Iwasaki, A. and Medzhitov, R., Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004. 5: 987995.
  • 3
    Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M. et al., A Toll-like receptor recognizes bacterial DNA. Nature 2000. 408: 740745.
  • 4
    Krieg, A. M., CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 2002. 20: 709760.
  • 5
    Ulevitch, R. J., Therapeutics targeting the innate immune system. Nat. Rev. Immunol. 2004. 4: 512520.
  • 6
    Bauer, S., Kirschning, C. J., Hacker, H., Redecke, V., Hausmann, S., Akira, S., Wagner, H. and Lipford, G. B., Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. USA 2001. 98: 92379242.
  • 7
    Hartmann, G., Battiany, J., Poeck, H., Wagner, M., Kerkmann, M., Lubenow, N., Rothenfusser, S. and Endres, S., Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. Eur. J. Immunol. 2003. 33: 16331641.
  • 8
    Jurk, M., Schulte, B., Kritzler, A., Noll, B., Uhlmann, E., Wader, T., Schetter, C. et al., C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level. Immunobiology 2004. 209: 141154.
  • 9
    Krug, A., Rothenfusser, S., Hornung, V., Jahrsdorfer, B., Blackwell, S., Ballas, Z. K., Endres, S. et al., Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur. J. Immunol. 2001. 31: 21542163.
  • 10
    Stunz, L. L., Lenert, P., Peckham, D., Yi, A. K., Haxhinasto, S., Chang, M., Krieg, A. M. et al., Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells. Eur. J. Immunol. 2002. 32: 12121222.
  • 11
    Zhu, F. G., Reich, C. F. and Pisetsky, D. S., Inhibition of murine dendritic cell activation by synthetic phosphorothioate oligodeoxynucleotides. J. Leukoc. Biol. 2002. 72: 11541163.
  • 12
    Yamada, H., Gursel, I., Takeshita, F., Conover, J., Ishii, K. J., Gursel, M., Takeshita, S. and Klinman, D. M., Effect of suppressive DNA on CpG-induced immune activation. J. Immunol. 2002. 169: 55905594.
  • 13
    Duramad, O., Fearon, K. L., Chan, J. H., Kanzler, H., Marshall, J. D., Coffman, R. L. and Barrat, F. J., IL-10 regulates plasmacytoid dendritic cell response to CpG-containing immunostimulatory sequences. Blood 2003. 102: 44874492.
  • 14
    Payvandi, F., Amrute, S. and Fitzgerald-Bocarsly, P., Exogenous and endogenous IL-10 regulate IFN-alpha production by peripheral blood mononuclear cells in response to viral stimulation. J. Immunol. 1998. 160: 58615868.
  • 15
    Zou, W., Borvak, J., Wei, S., Isaeva, T., Curiel, D. T. and Curiel, T. J., Reciprocal regulation of plasmacytoid dendritic cells and monocytes during viral infection. Eur. J. Immunol. 2001. 31: 38333839.
  • 16
    Gary-Gouy, H., Lebon, P. and Dalloul, A. H., Type I interferon production by plasmacytoid dendritic cells and monocytes is triggered by viruses, but the level of production is controlled by distinct cytokines. J. Interferon Cytokine Res. 2002. 22: 653659.
  • 17
    Blasius, A., Vermi, W., Krug, A., Facchetti, F., Cella, M. and Colonna, M., A cell-surface molecule selectively expressed on murine natural interferon-producing cells that blocks secretion of interferon-alpha. Blood 2004. 103: 42014206.
  • 18
    Fabricius, D., O'Dorisio, M. S., Blackwell, S. and Jahrsdorfer, B., Human plasmacytoid dendritic cell function: inhibition of IFN-alpha secretion and modulation of immune phenotype by vasoactive intestinal peptide. J. Immunol. 2006. 177: 59205927.
  • 19
    Shin, A., Toy, T., Rothenfusser, S., Robson, N., Vorac, J., Dauer, M., Stuplich, M. et al., P2Y receptor signaling regulates phenotype and IFN-{alpha} secretion of human plasmacytoid dendritic cells. Blood 2008. 111: 30623069.
  • 20
    Fanning, S. L., George, T. C., Feng, D., Feldman, S. B., Megjugorac, N. J., Izaguirre, A. G. and Fitzgerald-Bocarsly, P., Receptor cross-linking on human plasmacytoid dendritic cells leads to the regulation of IFN-alpha production. J. Immunol. 2006. 177: 58295839.
  • 21
    Heikenwalder, M., Polymenidou, M., Junt, T., Sigurdson, C., Wagner, H., Akira, S., Zinkernagel, R. and Aguzzi, A., Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat. Med. 2004. 10: 187192.
  • 22
    Blanco, P., Palucka, A. K., Gill, M., Pascual, V. and Banchereau, J., Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001. 294: 15401543.
  • 23
    Cederblad, B., Blomberg, S., Vallin, H., Perers, A., Alm, G. V. and Ronnblom, L., Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells. J. Autoimmun. 1998. 11: 465470.
  • 24
    Viglianti, G. A., Lau, C. M., Hanley, T. M., Miko, B. A., Shlomchik, M. J. and Marshak-Rothstein, A., Activation of autoreactive B cells by CpG dsDNA. Immunity 2003. 19: 837847.
  • 25
    Adachi, K., Tsutsui, H., Kashiwamura, S., Seki, E., Nakano, H., Takeuchi, O., Takeda, K. et al., Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J. Immunol. 2001. 167: 59285934.
  • 26
    Coban, C., Ishii, K. J., Kawai, T., Hemmi, H., Sato, S., Uematsu, S., Yamamoto, M. et al., Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 2005. 201: 1925.
  • 27
    Liew, F. Y., Xu, D., Brint, E. K. and O'Neill, L. A., Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 2005. 5: 446458.
  • 28
    Hemmi, H., Kaisho, T., Takeda, K. and Akira, S., The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J. Immunol. 2003. 170: 30593064.
  • 29
    Krug, A., French, A. R., Barchet, W., Fischer, J. A., Dzionek, A., Pingel, J. T., Orihuela, M. M. et al., TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 2004. 21: 107119.
  • 30
    Dalod, M., Salazar-Mather, T. P., Malmgaard, L., Lewis, C., Asselin-Paturel, C., Briere, F., Trinchieri, G. and Biron, C. A., Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 2002. 195: 517528.
  • 31
    Decker, P., Singh-Jasuja, H., Haager, S., Kotter, I. and Rammensee, H. G., Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation. J. Immunol. 2005. 174: 33263334.
  • 32
    Klinman, D. M., Takeshita, F., Gursel, I., Leifer, C., Ishii, K. J., Verthelyi, D. and Gursel, M., CpG DNA: recognition by and activation of monocytes. Microbes. Infect. 2002. 4: 897901.
  • 33
    Yasuda, K., Yu, P., Kirschning, C. J., Schlatter, B., Schmitz, F., Heit, A., Bauer, S. et al., Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways. J. Immunol. 2005. 174: 61296136.
  • 34
    Naik, S. H., Proietto, A. I., Wilson, N. S., Dakic, A., Schnorrer, P., Fuchsberger, M., Lahoud, M. H. et al., Cutting edge: generation of splenic CD8+ and CD8− dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 2005. 174: 65926597.
  • 35
    Boonstra, A., Rajsbaum, R., Holman, M., Marques, R., Asselin-Paturel, C., Pereira, J. P., Bates, E. E. et al., Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. J. Immunol. 2006. 177: 75517558.
  • 36
    Marshall, J. D., Fearon, K., Abbate, C., Subramanian, S., Yee, P., Gregorio, J., Coffman, R. L. and Van Nest, G., Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions. J. Leukoc. Biol. 2003. 73: 781792.
  • 37
    Krieg, A. M., Wu, T., Weeratna, R., Efler, S. M., Love-Homan, L., Yang, L., Yi, A. K. et al., Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl. Acad. Sci. USA 1998. 95: 1263112636.
  • 38
    Kerkmann, M., Costa, L. T., Richter, C., Rothenfusser, S., Battiany, J., Hornung, V., Johnson, J. et al., Spontaneous formation of nucleic acid-based nanoparticles is responsible for high interferon-alpha induction by CpG-A in plasmacytoid dendritic cells. J. Biol. Chem. 2005. 280: 80868093.
  • 39
    Honda, K., Yanai, H., Mizutani, T., Negishi, H., Shimada, N., Suzuki, N., Ohba, Y. et al., Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 2004. 101: 1541615421.
  • 40
    Kawai, T., Sato, S., Ishii, K. J., Coban, C., Hemmi, H., Yamamoto, M., Terai, K. et al., Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 2004. 5: 10611068.
  • 41
    Uematsu, S., Sato, S., Yamamoto, M., Hirotani, T., Kato, H., Takeshita, F., Matsuda, M. et al., Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction. J. Exp. Med. 2005. 201: 915923.
  • 42
    Babiuk, S., Mookherjee, N., Pontarollo, R., Griebel, P., van Drunen Littel-van den Hurk, S., Hecker, R. and Babiuk, L., TLR9−/− and TLR9+/+ mice display similar immune responses to a DNA vaccine. Immunology 2004. 113: 114120.
  • 43
    Spies, B., Hochrein, H., Vabulas, M., Huster, K., Busch, D. H., Schmitz, F., Heit, A. and Wagner, H., Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice. J. Immunol. 2003. 171: 59085912.
  • 44
    Stetson, D. B. and Medzhitov, R., Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 2006. 24: 93103.
  • 45
    Barrat, F. J., Meeker, T., Gregorio, J., Chan, J. H., Uematsu, S., Akira, S., Chang, B. et al., Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med. 2005. 202: 11311139.
  • 46
    Lund, J. M., Alexopoulou, L., Sato, A., Karow, M., Adams, N. C., Gale, N. W., Iwasaki, A. and Flavell, R. A., Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 2004. 101: 55985603.
  • 47
    Kato, H., Sato, S., Yoneyama, M., Yamamoto, M., Uematsu, S., Matsui, K., Tsujimura, T. et al., Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005. 23: 1928.
  • 48
    Grutz, G., New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J. Leukoc. Biol. 2005. 77: 315.
  • 49
    Mizuno, T., Sawada, M., Marunouchi, T. and Suzumura, A., Production of interleukin-10 by mouse glial cells in culture. Biochem. Biophys. Res. Commun. 1994. 205: 19071915.
  • 50
    Moore, K. W., O'Garra, A., de Waal, M. R., Vieira, P. and Mosmann, T. R., Interleukin-10. Annu. Rev. Immunol. 1993. 11: 165190.
  • 51
    Mosmann, T. R., Properties and functions of interleukin-10. Adv. Immunol. 1994. 56: 126.
  • 52
    Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. and Muller, W., Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993. 75: 263274.
  • 53
    Siewe, L., Bollati-Fogolin, M., Wickenhauser, C., Krieg, T., Muller, W. and Roers, A., Interleukin-10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA. Eur. J. Immunol. 2006. 36: 32483255.
  • 54
    Haig, D. M. and McInnes, C. J., Immunity and counter-immunity during infection with the parapoxvirus orf virus. Virus Res. 2002. 88: 316.
  • 55
    Maloney, G., Schroder, M. and Bowie, A. G., Vaccinia virus protein A52R activates p38 mitogen-activated protein kinase and potentiates lipopolysaccharide-induced interleukin-10. J. Biol. Chem. 2005. 280: 3083830844.
  • 56
    McFadden, G. and Murphy, P. M., Host-related immunomodulators encoded by poxviruses and herpesviruses. Curr. Opin. Microbiol. 2000. 3: 371378.
  • 57
    Stojdl, D. F., Lichty, B. D., tenOever, B. R., Paterson, J. M., Power, A. T., Knowles, S., Marius, R. et al., VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 2003. 4: 263275.